MedTrace Logo

Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

NCT06016946 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2025-06-17

No results posted yet for this study

Summary

This project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.

Conditions

  • Friedreich Ataxia

Sponsors & Collaborators

  • Friedreich's Ataxia Research Alliance

    lead OTHER

Principal Investigators

  • David Lynch, MD · Children's Hospital of Philadelphia

  • Jorg B Schulz, Prof · University Hospital, Aachen

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-28
Primary Completion
2048-01-28
Completion
2048-01-28

Countries

  • United States
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Czechia
  • France
  • Germany
  • Greece
  • India
  • Ireland
  • Italy
  • Netherlands
  • New Zealand
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06016946 on ClinicalTrials.gov